IL88224A0 - Peptides,artificial antigens and immunoassay kits - Google Patents

Peptides,artificial antigens and immunoassay kits

Info

Publication number
IL88224A0
IL88224A0 IL88224A IL8822488A IL88224A0 IL 88224 A0 IL88224 A0 IL 88224A0 IL 88224 A IL88224 A IL 88224A IL 8822488 A IL8822488 A IL 8822488A IL 88224 A0 IL88224 A0 IL 88224A0
Authority
IL
Israel
Prior art keywords
pct
antigen
artificial
hiv
epitope
Prior art date
Application number
IL88224A
Other languages
English (en)
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20370026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL88224(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of IL88224A0 publication Critical patent/IL88224A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL88224A 1987-10-28 1988-10-28 Peptides,artificial antigens and immunoassay kits IL88224A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser

Publications (1)

Publication Number Publication Date
IL88224A0 true IL88224A0 (en) 1989-06-30

Family

ID=20370026

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88224A IL88224A0 (en) 1987-10-28 1988-10-28 Peptides,artificial antigens and immunoassay kits

Country Status (11)

Country Link
US (1) US5981170A (de)
EP (1) EP0396559B1 (de)
JP (2) JP2818797B2 (de)
AT (1) ATE141286T1 (de)
DE (1) DE3855479T2 (de)
DK (1) DK104590A (de)
FI (1) FI902143A0 (de)
IL (1) IL88224A0 (de)
NO (1) NO302369B1 (de)
SE (1) SE8704185L (de)
WO (1) WO1989003844A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
CA2350911A1 (en) 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Hiv-specific t-cell induction
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7094884B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
CA2449747C (en) 2001-06-22 2010-04-13 F. Hoffmann-La Roche Ag Use of fkbp chaperones as expression tool
US7615530B2 (en) * 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
JPWO2005040799A1 (ja) * 2003-10-29 2007-04-19 岡田 秀親 相補性ペプチド人工抗体
CA2632703A1 (en) 2005-10-25 2008-03-13 Louisiana Tech University Research Foundation Multilayer films, coatings and microcapsules comprising polypeptides
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharmaceutical Corp., Raritan Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
EP0247557B1 (de) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV)Decke-Peptide
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern

Also Published As

Publication number Publication date
WO1989003844A1 (en) 1989-05-05
DK104590A (da) 1990-06-26
JPH10101697A (ja) 1998-04-21
JP2818797B2 (ja) 1998-10-30
SE8704185D0 (sv) 1987-10-28
NO901899L (no) 1990-04-27
DE3855479T2 (de) 1997-01-02
JP3231666B2 (ja) 2001-11-26
NO302369B1 (no) 1998-02-23
ATE141286T1 (de) 1996-08-15
SE8704185L (sv) 1989-04-29
US5981170A (en) 1999-11-09
EP0396559B1 (de) 1996-08-14
DK104590D0 (da) 1990-04-27
FI902143A0 (fi) 1990-04-27
DE3855479D1 (de) 1996-09-19
EP0396559A1 (de) 1990-11-14
JPH03500648A (ja) 1991-02-14
NO901899D0 (no) 1990-04-27

Similar Documents

Publication Publication Date Title
IL88224A0 (en) Peptides,artificial antigens and immunoassay kits
IL82847A0 (en) Improved peptide composition and method for the detection of antidibodies to htlv-iii
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
ATE375516T1 (de) Immuntest zur messung des humanen c-peptides sowie reagenzienkit hierfür
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
Child et al. A review of the applications of immunochemistry to archaeological bone
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
Obinata et al. Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle
KR870011154A (ko) Htlv-iii바이러스 관련 펩티드, 이에 대한 항체, 백신, aids 바이러스에 대한 수동 및 자동 면역 및 aids 바이러스의 혈청학적 진단을 위한 진단시험
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
DE69015708D1 (de) Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
AU638155B2 (en) Peptides with a characteristic antigenic determinant for alphal-microglobulin
EP0331514A3 (de) Prüfung der Deletion oder des Mangels an Protein von Duchenne-Muskeldystrophie
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
KR910007962A (ko) Hiv 관련 펩티드
EP0985931A3 (de) Rekombinantes-Antigen-Immunoassay zur Diagnose von Syphilis
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
TH62264A (th) Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv

Legal Events

Date Code Title Description
HP Change in proprietorship
KB Patent renewed
RH1 Patent not in force